A startup leveraging its proprietary language processing technology, SATOMI®, to support the automatic generation of medical records and referral letters. By streamlining information use in clinical settings, it promotes regional collaboration and medical DX, contributing to the development of a sustainable healthcare system.
[画像1: https://prtimes.jp/i/81736/10/resize/d81736-10-65ec8b9a3715fdbf1dde-0.jpg ] 医療向けAIソフトウェアの開発を行うエニシア株式会社（本社：京都市左京区、代表取締役：小東茂夫、以下、エニシア）...
[画像1: https://prtimes.jp/i/81736/9/resize/d81736-9-a0897ae7ecb1f6580270-0.jpg ] 医療向けAIソフトウェア開発を行うエニシア株式会社（本社：京都市左京区、代表取締役：小東茂夫、以下、エニシア）は、...
[画像1: https://prtimes.jp/i/81736/8/resize/d81736-8-edca2d6e9b8e1026aaa8-3.jpg ] 医療向けAIソフトウェア開発を行うエニシア株式会社（本社：京都市左京区、代表取締役：小東茂夫、以下、エニシア）は、A...
カルテ構造化APIサービスは、医療テキストを目的に応じて整理するサービスです。独自の医療言語処理技術『SATOMI(R)』を応用し、カルテなどの医療テキストを目的に応じた形に自動で整理することで、これまで利...
A startup has developed a painless, simple test using tears to detect cancer early and monitor for recurrence. Using cutting-edge technology originating from Kobe University, it enables highly sensitive detection of extracellular vesicles, allowing testing in everyday settings like homes or pharmacies.
Luxana Biotech is a preclinical antisense oligonucleotide (ASO) development company based on proprietary nucleic acids with unique cross-linking structures. We have created the LuxiAP™ ASO drug discovery platform for the central nervous system and ophthalmic fields. The company has collaborative research agreements with multiple pharmaceutical companies and maintains its own ASO pipeline. We are seeking to expand partnership opportunities not only for collaborative research with pharmaceutical companies but also for joint development utilizing our proprietary pipeline.
EX-Fusion is Japan’s only private company dedicated to the commercialization of laser fusion reactors. This breakthrough technology has the potential to replace conventional energy sources and play a vital role in achieving carbon neutrality by 2050.
Leveraging world-leading autophagy measurement technology, we provide end-to-end solutions from material evaluation and supplement/cosmetic development to drug discovery research. A startup demonstrating results in international competitions, aiming for the societal implementation of extended healthy lifespans.
